| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
centromere protein T | 0.821 | 0.231 | 5.8E-06 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
ETHE1 persulfide dioxygenase | 0.686 | 0.346 | 4.6E-06 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
THAP domain containing 11 | 0.769 | 0.346 | 0.83 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
mitochondrial trans-2-enoyl-CoA reductase | 0.736 | 0.385 | 2.2E-05 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
WD repeat domain 45 | 0.647 | 0.423 | 0.99 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
interferon regulatory factor 2 binding protein like | 0.631 | 0.462 | 0.84 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
BR serine/threonine kinase 2 | 0.700 | 0.500 | 0.95 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
purine rich element binding protein A | 0.644 | 0.500 | 0.94 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
SPG11 vesicle trafficking associated, spatacsin | 0.576 | 0.538 | 1.6E-39 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2009 | 2009 | ||||||||
|
calcium/calmodulin dependent protein kinase II alpha | 0.612 | 0.538 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 8 | 2017 | 2017 | ||||||||
|
calcium/calmodulin dependent protein kinase II beta | 0.626 | 0.538 | 0.74 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2017 | 2017 | ||||||||
|
oligophrenin 1 | 0.633 | 0.538 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
TTN antisense RNA 1 | 0.599 | 0.577 |
|
disease | 0.100 | None | 0 | 3 | ||||||||||||
|
component of oligomeric golgi complex 4 | 0.631 | 0.615 | 4.0E-09 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||
|
ATPase H+ transporting V1 subunit A | 0.579 | 0.615 | 0.87 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
thyroid hormone receptor interactor 11 | 0.595 | 0.654 | 1.7E-12 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||
|
glutamate ionotropic receptor AMPA type subunit 3 | 0.566 | 0.692 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
sodium voltage-gated channel alpha subunit 4 | 0.554 | 0.731 | 1.3E-02 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2004 | 2008 | ||||||||
|
collagen type VI alpha 1 chain | 0.587 | 0.731 | 1.00 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||
|
sodium voltage-gated channel alpha subunit 2 | 0.518 | 0.731 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
NPC intracellular cholesterol transporter 2 | 0.612 | 0.769 | 1.8E-03 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
dynein cytoplasmic 1 heavy chain 1 | 0.547 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
dual specificity tyrosine phosphorylation regulated kinase 1A | 0.533 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
muscle associated receptor tyrosine kinase | 0.570 | 0.769 | 4.2E-08 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||
|
piezo type mechanosensitive ion channel component 2 | 0.529 | 0.769 | 8.1E-07 |
|
disease | 0.100 | None | 0 | 2 |